(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

XIAFLEX COLLAGENASE CLOSTRIDIUM HISTOLYTICUM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

XIAFLEX COLLAGENASE CLOSTRIDIUM HISTOLYTICUM

ST13

US500000077883942

Class

5

Filing

77883942

Registration

3862018

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

44

Latest update

06/28/2024

Trademark type

Combined

Nice classes

5

Filing date

12/02/2009

Registration date

10/12/2010

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/21/2019

Last transaction

11/21/2019

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/03/2010

First use in commerce

02/03/2010

Drawing code

3

Owner type

24

Owner location

BALLSBRIDGE, IE

Examiner

MAKHDOOM,SAIMA

Law office

L10

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the word mark "XIAFLEX" shown in blue with an orange wave design completing the "A" and "F". The words "COLLAGENASE CLOSTRIDIUM HISTOLYTICUM" are shown in grey beneath "XIAFLEX".

Holders and representatives

Holders

ENDO BIOLOGICS LIMITED
E. V. (pessoa física)
A. U. (pessoa física)
Auxilium US Holdings, LLC.

Representatives

Camille M. Miller Cozen O'Connor

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationscollagenase enzyme used to treat fibroproliferative disease conditions such as Dupuytren's contracturePeyronie's disease and Frozen Shoulder Syndrome also known as Adhesive Capsulitis

Publications

History of USPTO decisions and trademark events.

44 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/28/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/01/2024

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/22/2021

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/03/2020

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

11/21/2019

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

11/21/2019

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

11/21/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/21/2019

E89R

TEAS SECTION 8 & 9 RECEIVED

10/14/2019

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

10/12/2019

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/10/2016

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/04/2015

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/04/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/04/2015

E815

TEAS SECTION 8 & 15 RECEIVED

10/12/2015

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/12/2015

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/25/2015

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/25/2015

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

03/04/2015

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/04/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

10/12/2010

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/07/2010

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

09/06/2010

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/06/2010

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/02/2010

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/02/2010

IUAF

USE AMENDMENT FILED

08/09/2010

EISU

TEAS STATEMENT OF USE RECEIVED

08/09/2010

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/13/2010

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/18/2010

PUBO

PUBLISHED FOR OPPOSITION

05/18/2010

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/12/2010

ALIE

ASSIGNED TO LIE

04/12/2010

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/25/2010

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/16/2010

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/16/2010

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/16/2010

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/13/2010

GNRT

NON-FINAL ACTION E-MAILED

03/13/2010

CNRT

NON-FINAL ACTION WRITTEN

03/13/2010

DOCK

ASSIGNED TO EXAMINER

03/06/2010

MDSC

NOTICE OF DESIGN SEARCH CODE MAILED

12/09/2009

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/08/2009

NWAP

NEW APPLICATION ENTERED

12/05/2009

Continuous trademark protection

Get notified about every new filing that threatens XIAFLEX COLLAGENASE CLOSTRIDIUM HISTOLYTICUM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.